Lumexa Imaging HoldingsLMRI +14.37%8 PB Ratio is 1.94 as of Jun. 28, 2026, which is at its 10-year median of 1.94. GuruFocus rates LMRI with a GF Score™ of 8/100. The stock has 2 warning signs investors should review. Among 787 Medical Devices & Instruments companies, Lumexa Imaging Holdings ranks better than 51.33% on this metric.
The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.
Be Aware
Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, Lumexa Imaging Holdings's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Lumexa Imaging Holdings PB Ratio vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Lumexa Imaging Holdings's PB Ratio distribution charts can be found below:
* The bar in red indicates where Lumexa Imaging Holdings's PB Ratio falls into.
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.
Lumexa Imaging Holdings (LMRI) has a PB Ratio of 1.94 as of Jun. 28, 2026. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Lumexa Imaging Holdings and its competitors. This is near median its historical median of 1.94. Over the past decade, Lumexa Imaging Holdings' PB Ratio has ranged from 1.13 to 10.49. According to the industry distribution chart, Lumexa Imaging Holdings ranks #383 out of 787 companies in the Medical Devices & Instruments industry, placing it in the top 48.7%.
Is Lumexa Imaging Holdings' PB Ratio too high?
Lumexa Imaging Holdings' current PB Ratio of 1.94 is near median its 10-year median of 1.94. Over the past 10 years, this metric has ranged from a low of 1.13 to a high of 10.49. The Medical Devices & Instruments industry median PB Ratio is 1.99. Lumexa Imaging Holdings' value of 1.94 is 2.5% below this industry median. Based on the distribution chart, Lumexa Imaging Holdings ranks #383 out of 787 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Lumexa Imaging Holdings has a GF Score™ of 8/100, reflecting its overall financial health beyond just this single metric.
How does Lumexa Imaging Holdings' PB Ratio compare to SSII and CBLL?
According to the Medical Devices & Instruments industry distribution chart, Lumexa Imaging Holdings ranks #383 out of 787 companies for PB Ratio. This puts Lumexa Imaging Holdings in the upper half of its industry. The industry median PB Ratio is 1.99. Lumexa Imaging Holdings' value of 1.94 is 2.5% below this benchmark. Historically, Lumexa Imaging Holdings' own PB Ratio has ranged from 1.13 to 10.49 over the past decade. While the company's 10-year median is 1.94 vs. the industry median of 1.99, Lumexa Imaging Holdings has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PB Ratio for a Medical Devices & Instruments company?
The median PB Ratio among Medical Devices & Instruments companies is 1.99, based on 787 companies in the industry. Companies in the top quartile (top 25%) have a PB Ratio significantly above this median, while those in the bottom quartile fall well below. However, PB Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Lumexa Imaging Holdings's current PB Ratio of 1.94 is 2.5% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PB Ratio mean?
A high PB Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Lumexa Imaging Holdings and its competitors. For the Medical Devices & Instruments industry, the median PB Ratio is 1.99 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Lumexa Imaging Holdings's current PB Ratio is 1.94, which is near median its own 10-year median of 1.94. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Lumexa Imaging Holdings stock overvalued right now?
Lumexa Imaging Holdings (LMRI) has a current PB Ratio of 1.94. The current PB Ratio is 1.94, which is near median its 10-year median of 1.94 and 2.5% below the Medical Devices & Instruments industry median of 1.99. Lumexa Imaging Holdings' overall GF Score™ is 8/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PB Ratio calculated?
PB Ratio is calculated from a company's financial statements. For Lumexa Imaging Holdings (LMRI), the current PB Ratio is 1.94 as of Jun. 28, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Lumexa Imaging Holdings Inc is a provider of diagnostic imaging services. The company offers a broad range of imaging modalities, including MRI, CT, PET, X-ray, ultrasound, and mammography. Its products and operations are managed and reported in two operating segments: Outpatient Imaging Centers (Outpatient) and Professional Services (Professional). The professional services segment generates revenue from interpreting imaging studies conducted by other parties, mainly hospital imaging departments. The majority of revenue is generated by the Outpatient segment, which performs imaging studies and provides radiologists' interpretations of those studies.
8GF Score
Get the complete analysis for LMRI
PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
LMRI has been successfully added to your 